Skip to content
Recall Observatory FDA recall evidence

Drug product

TRAVOPROST OPHTHALMIC SOLUTION, USP 0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPS

D-0425-2021

March 15, 2021

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 87512
Status
Terminated
Classification
Class II
Quantity
325 CARTONS
Official record key
drug-enforcement:D-0425-2021

Official wording

Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Code information: RW4409

Distribution pattern: FL, GA, SC

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations